Showing results (1-10 of 10) with videos related to

Sort By:
Pageof 1
Gene|December 4, 2023
The accumulation of sphingosine kinase 2 disrupts the DNA damage response and promotes resistance to genotoxic agentsGabriel da Silva, Thaís Moré Milan, Andréia Machado Leopoldino
The American Journal of Pathology|October 30, 2024
Sphingosine Kinase 2 Controls the Aggressive Phenotype of Oral Squamous Cell Carcinoma by Regulating miR-205 and miR-296 through p53Thaís Moré Milan, Gabriel Silva, Lucas Oliveira Sousa, et al.
ACS Omega|January 1, 2026
miR-205 Enhances Sensitivity to Genotoxic Agents in HNSCC Cells and Blocks Sphingosine Kinase 2 Action in TumorigenicityThaís Moré Milan, Gabriel da Silva, Graziella Ribeiro de Sousa, et al.
Archives of Oral Biology|June 9, 2022
Epigenetic modifications control loss of adhesion and aggressiveness of cancer stem cells derived from head and neck squamous cell carcinoma with intrinsic resistance to cisplatinThaís Moré Milan, Ana Patrícia Espaladori Eskenazi, Rayana Longo Bighetti-Trevisan, et al.
Epigenomics|December 24, 2025
High level of <i>KMT5C</i> is associated to better prognosis and its knockdown increases proliferation in head and neck cancerLucas Oliveira Sousa, Gabriel da Silva, Thaís Moré Milan, et al.
Journal of Oral Pathology & Medicine : Official Publication of the International Association of Oral Pathologists and the American Academy of Oral Pathology|June 9, 2022
Pharmacological inhibition of HDAC6 overcomes cisplatin chemoresistance by targeting cancer stem cells in oral squamous cell carcinomaMarcela Oliveira Tavares, Thaís Moré Milan, Rayana Longo Bighetti-Trevisan, et al.
Epigenomics|December 22, 2023
SET protein as an epigenetics targetGabriel da Silva, Thaís Moré Milan, Pablo Shimaoka Chagas, et al.
Oral Diseases|April 11, 2022
Epithelial-mesenchymal transition and cancer stem cells: A route to acquired cisplatin resistance through epigenetics in HNSCCJulia Lima de Oliveira, Thaís Moré Milan, Rayana Longo Bighetti-Trevisan, et al.
Cellular Signalling|June 18, 2023
Interplay between EZH2/β-catenin in stemness of cisplatin-resistant HNSCC and their role as therapeutic targetsThaís Moré Milan, Ana Patrícia Espaladori Eskenazi, Lucas Dias de Oliveira, et al.
Journal of Cellular Physiology|December 27, 2023
Up-regulation of TNF-alpha/NFkB/SIRT1 axis drives aggressiveness and cancer stem cells accumulation in chemoresistant oral squamous cell carcinomaLetícia Rodrigues de Castro, Lucas Dias de Oliveira, Thaís Moré Milan, et al.
Pageof 1